{"id":"NCT00560885","sponsor":"AtriCure, Inc.","briefTitle":"AtriCure Bipolar Radiofrequency Ablation of Permanent Atrial Fibrillation","officialTitle":"AtriCure Synergy Bipolar RF Energy Lesions for Permanent Atrial Fibrillation Treatment During Concomitant On-Pump Endo/Epicardial Cardiac Surgery","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-11","primaryCompletion":"2009-12","completion":"2012-12","firstPosted":"2007-11-20","resultsPosted":"2013-03-14","lastUpdate":"2013-03-29"},"enrollment":55,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Atrial Fibrillation"],"interventions":[{"type":"DEVICE","name":"AtriCure Bipolar System","otherNames":[]}],"arms":[{"label":"AtriCure Bipolar System","type":"EXPERIMENTAL"}],"summary":"ABLATE is a prospective, non-randomized multi-center clinical trial to demonstrate the safety and effectiveness of the AtriCure Bipolar System for treating permanent atrial fibrillation during concomitant on-pump cardiac surgery.","primaryOutcome":{"measure":"Percent of Patients Free From AF and Off Class I and III Anti-arrhythmic Drugs as Determined by Holter Monitoring at 6 Months.","timeFrame":"6 Months Post Procedure","effectByArm":[{"arm":"AtriCure Bipolar System","deltaMin":74,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":9,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":45,"n":55},"commonTop":["Anaemia","Pleural effusion","Bradycardia","Haemorrhage","Cardiac Failure Congestive"]}}